Todd Christopher Longsworth, General Counsel at NovoCure Ltd (NVCR), sold 158,040 shares at $89.86 ($13.9M) on 2019-09-03, disclosed to the SEC on 2019-09-05.
Open-market sale of $13.9M NVCR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.85 | 22,264 | $1.9M | 13.9% |
| 2 | $86.86 | 11,426 | $992K | 7.1% |
| 3 | $86.88 | 4,238 | $368K | 2.7% |
| 4 | $86.95 | 20,891 | $1.8M | 13.1% |
| 5 | $88.17 | 28,340 | $2.5M | 18.0% |
| 6 | $88.18 | 14,888 |
| $1.3M |
| 9.5% |
| 7 | $88.19 | 6,065 | $535K | 3.9% |
| 8 | $88.22 | 24,083 | $2.1M | 15.3% |
| 9 | $88.82 | 6,616 | $588K | 4.2% |
| 10 | $88.86 | 2,900 | $258K | 1.9% |
| 11 | $88.94 | 929 | $83K | 0.6% |
| 12 | $88.97 | 7,869 | $700K | 5.0% |
| 13 | $89.86 | 1,200 | $108K | 0.8% |
| 14 | $89.87 | 4,031 | $362K | 2.6% |
| 15 | $89.90 | 2,300 | $207K | 1.5% |
| Total | $87.87 avg | 158,040 | $13.9M | 100% |
| Filing → |
| NVCR | SELL | 2021-03-10 | $629K | — | Filing → |
| NVCR | SELL | 2021-03-08 | $848K | — | Filing → |
| NVCR | SELL | 2021-03-04 | $716K | — | Filing → |